Pancreatic Cancer
Conditions
Keywords
Quality of Life, Health-Illness Transition, 20-038
Brief summary
The purpose of this study is to better understand what types of transitions people with pancreatic cancer face when they receive chemotherapy. Again, this study defines transition as a change in a life situation or a status that causes a change in a person's identity, role, behavior, or personal relationships. Examples of transitions include changes in sleeping habits, anxiety, employment, relationship with a higher power, and treatment goals.
Interventions
BEHAVIORALMeasurement of Transitions in Cancer Scale (MOT-CA) Survey
These surveys will take 5-10 minutes to complete at two time-points, T0 (baseline) and T1 (four to six weeks after baseline visit) The patient will again complete the DT and MOT-CA at a chemotherapy treatment or clinic visit, if possible, or via a telephone call with the principal investigator in the event that there are no in-person visits scheduled (Time 1).
BEHAVIORALDistress Thermometer Survey
These surveys will take 5-10 minutes to complete at two time-points, T0 (baseline) and T1 (four to six weeks after baseline visit).The patient will again complete the DT and MOT-CA at a chemotherapy treatment or clinic visit, if possible, or via a telephone call with the principal investigator in the event that there are no in-person visits scheduled (Time 1).
Sponsors
Memorial Sloan Kettering Cancer Center
Hunter College School of Nursing
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* adult patients 18 years of age and older * primary language listed as English in electronic medical record * biopsy proven diagnosis of pancreatic cancer * within three months after initiating a chemotherapy regimen at the Rockefeller Outpatient Pavilion at MSKCC (patient may have previously received chemotherapy at an outside institution or may have received previous chemotherapy regimens at MSKCC).
Exclusion criteria
* previous history of cancer within the past five years, except for non-melanoma skin cancer, ductal carcinoma in situ breast cancer, and thyroid cancer.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Extent of the change experienced by patients with pancreatic cancer | 4 to 6 weeks after baseline | Descriptive statistics will be calculated at both time points using (part A on the MOT-CA) for each of the seven transition domains (physical, emotional, social, spiritual, cancer status, treatment, and approach) at both time points (Time 0 and Time 1). |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORJessica Goldberg, RN, MSN, AGPCNP-BC, ACHPN
Memorial Sloan Kettering Cancer Center
Outcome results
None listed